Total Payments
$5,632
2024 Payments
$538.36
Companies
27
Transactions
320
Medicare Patients
5,358
Medicare Billing
$487,985
Payment Breakdown by Category
Food & Beverage$5,620 (99.8%)
Education$12.04 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,620 | 318 | 99.8% |
| Education | $12.04 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,580 | 53 | $0 (2024) |
| PFIZER INC. | $822.30 | 90 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $641.00 | 28 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $598.11 | 26 | $0 (2021) |
| Lilly USA, LLC | $352.97 | 19 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $249.13 | 13 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $248.67 | 13 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $215.61 | 18 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $195.04 | 13 | $0 (2022) |
| GlaxoSmithKline, LLC. | $120.21 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $538.36 | 28 | Novo Nordisk Inc ($215.22) |
| 2023 | $507.75 | 27 | Bayer Healthcare Pharmaceuticals Inc. ($116.52) |
| 2022 | $812.92 | 35 | Novo Nordisk Inc ($221.15) |
| 2021 | $887.15 | 37 | Novo Nordisk Inc ($417.57) |
| 2020 | $576.65 | 32 | PFIZER INC. ($169.01) |
| 2019 | $983.92 | 54 | Novo Nordisk Inc ($289.91) |
| 2018 | $745.07 | 59 | PFIZER INC. ($233.09) |
| 2017 | $580.40 | 48 | Janssen Pharmaceuticals, Inc ($170.15) |
All Payment Transactions
320 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $114.16 | General |
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: Respiratory | ||||||
| 08/01/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Cardio-renal | ||||||
| 07/15/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $3.39 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.63 | General |
| Category: Gastroenterology | ||||||
| 06/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardio-renal | ||||||
| 04/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $10.98 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/27/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.22 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: Cardio-renal | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Respiratory | ||||||
| 02/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.34 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Respiratory | ||||||
| 02/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/22/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 02/15/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $18.69 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 15 | 1,122 | 3,167 | $254,075 | $94,585 |
| 2021 | 21 | 1,893 | 6,822 | $502,295 | $181,582 |
| 2020 | 27 | 2,343 | 7,757 | $584,970 | $211,818 |
Total Patients
5,358
Total Services
17,746
Medicare Billing
$487,985
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 85 | 861 | $103,320 | $42,298 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 176 | 292 | $54,020 | $24,928 | 46.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 89 | 149 | $19,370 | $9,511 | 49.1% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 37 | 49 | $14,210 | $6,161 | 43.4% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2022 | 37 | 47 | $8,695 | $3,632 | 41.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 31 | 36 | $3,060 | $1,842 | 60.2% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 157 | 234 | $9,360 | $1,805 | 19.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 88 | 138 | $5,520 | $1,381 | 25.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 181 | 326 | $3,260 | $971.46 | 29.8% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 11 | 13 | $2,000 | $894.80 | 44.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 83 | 443 | $13,290 | $374.12 | 2.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 35 | 36 | $1,260 | $347.31 | 27.6% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 20 | 21 | $1,260 | $345.28 | 27.4% |
| 81002 | Urinalysis, manual test | Office | 2022 | 13 | 14 | $210.00 | $48.40 | 23.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 79 | 508 | $15,240 | $45.02 | 0.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 107 | 1,508 | $180,960 | $74,999 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 234 | 549 | $101,565 | $47,171 | 46.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 144 | 319 | $41,470 | $20,263 | 48.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 52 | 68 | $19,720 | $8,703 | 44.1% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Facility | 2021 | 58 | 67 | $12,395 | $5,244 | 42.3% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Facility | 2021 | 36 | 70 | $11,160 | $4,638 | 41.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 221 | 474 | $18,960 | $3,668 | 19.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 160 | 355 | $14,200 | $3,543 | 24.9% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 47 | 47 | $4,700 | $3,111 | 66.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 37 | 44 | $3,740 | $2,258 | 60.4% |
About Kevin Kelly
Kevin Kelly is a Family Medicine healthcare provider based in Russellville, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710972385.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kevin Kelly has received a total of $5,632 in payments from pharmaceutical and medical device companies, with $538.36 received in 2024. These payments were reported across 320 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($5,620).
As a Medicare-enrolled provider, Kelly has provided services to 5,358 Medicare beneficiaries, totaling 17,746 services with total Medicare billing of $487,985. Data is available for 3 years (2020–2022), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Russellville, AL
- Active Since 09/20/2005
- Last Updated 03/28/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710972385
Products in Payments
- Ozempic (Drug) $738.39
- BREZTRI (Drug) $483.96
- RYBELSUS (Drug) $433.68
- INVOKANA (Drug) $321.77
- CHANTIX (Drug) $309.14
- MOUNJARO (Drug) $297.03
- XARELTO (Drug) $270.32
- Kerendia (Drug) $249.13
- ENTRESTO (Drug) $248.67
- LYRICA (Drug) $162.01
- JANUVIA (Drug) $142.29
- FARXIGA (Drug) $141.32
- Tresiba (Drug) $133.01
- Rybelsus (Drug) $130.01
- COLOGUARD (Device) $113.06
- Trintellix (Drug) $102.56
- VIAGRA (Drug) $98.06
- TRINTELLIX (Drug) $77.41
- LINZESS (Drug) $57.78
- VRAYLAR (Drug) $56.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Russellville
Dr. Harry Kuberg, M.d, M.D
Family Medicine — Payments: $16,095
Family Medicine $16,095
Dr. Steven Zeller, M.d, M.D
Family Medicine — Payments: $8,880
Family Medicine $8,880
Katherine Gilliam, Do, DO
Family Medicine — Payments: $5,253
Family Medicine $5,253
Nathan Nielson, Do, DO
Family Medicine — Payments: $3,724
Family Medicine $3,724
Chenyi Chenyi, Md, MD
Family Medicine — Payments: $1,515
Family Medicine $1,515
Dr. Andrew Monfee, M.d, M.D
Family Medicine — Payments: $1,150
Family Medicine $1,150